Evidence map›Paper›PMID 33659005›Full record

ArticleFrontiers in immunology2021

A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis.

Samir V Parikh, Ana Malvar, John Shapiro, James M Turman, Huijuan Song, Valeria Alberton, Bruno Lococo, Juan M Mejia-Vilet, Sethu Madhavan, Jianying Zhang and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Lupus Nephritis from Pathogenesis to New Therapies: An Update.International journal of molecular sciences · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Samir V ParikhDivision of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Ana MalvarNephrology Unit, Hospital Fernandez, Buenos Aires, Argentina.
John ShapiroDivision of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
James M TurmanDivision of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Huijuan SongDivision of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Valeria AlbertonDepartment of Pathology, Hospital Fernandez, Buenos Aires, Argentina.
Bruno LococoNephrology Unit, Hospital Fernandez, Buenos Aires, Argentina.
Juan M Mejia-ViletDepartment of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
Sethu MadhavanDivision of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Jianying ZhangDepartment of Biomedical Informatics, The Ohio State University, Columbus, OH, United States.
Lianbo YuDepartment of Biomedical Informatics, The Ohio State University, Columbus, OH, United States.
Anjali A SatoskarDivision of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Dan BirminghamDivision of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Wael N JarjourDivision of Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Brad H RovinDivision of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Latha P GanesanDivision of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
The Ohio State University Wexner Medical Center · USHospital Fernández · ARThe Ohio State University · USInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MX

Funding

Immune Complex Elimination by Sinusoid Endothelial FcgRIIb: Mechanism and DiseaseR01AR066330 · NIAMS · OHIO STATE UNIVERSITY · PI ANDERSON, CLARK L, GANESAN, LATHA PRABHA · 2014 to 2018
$1.7M
NIAMS NIH HHS R01 AR066330
6 · The paper itself

Abstract

The mechanisms that promote local inflammatory injury during lupus nephritis (LN) flare are largely unknown. Understanding the key immune cells that drive intrarenal inflammation will advance our knowledge of disease pathogenesis and inform the development of new therapeutics for LN management. In this study, we analyzed kidney biopsies from patients with proliferative LN and identified a novel inflammatory dendritic cell (infDC) population that is highly expressed in the LN kidney, but minimally present in healthy human kidneys. During an agnostic evaluation of immune transcript expression in the kidneys of patients with proliferative LN, the most abundantly overexpressed transcript from isolated glomeruli was

Indexed as

Adaptive ImmunityAutoimmunityBiomarkersCells, CulturedDendritic CellsHumansImmunophenotypingInflammationKidneyLupus NephritisLymphocyte ActivationReceptors, FcT-LymphocytesBiomarkersFCER1G, humanReceptors, Fcadaptive immune responseautoimmunityinflammatory dendritic cellskidneylupus nephritisSLET cells

Identifiers

PMID33659005
PMCPMC7919935
OpenAlexW3132950539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.